ECTRIMS/EAN consensus on vaccination in people with multiple sclerosis: Improving immunization strategies in the era of highly active immunotherapeutic drugs
Susana Otero‐Romero(Vall d'Hebron Hospital Universitari), Mar Tintoré(Vall d'Hebron Hospital Universitari), Mauricio Farez(Fundación para la Lucha contra las Enfermedades Neurológicas de la Infancia), Rosa Juuti(Multiple Sclerosis International Federation), Magda Campins(Vall d'Hebron Hospital Universitari), Bernhard Hemmer(TUM Klinikum), Sandra Vukusic(Institut NeuroMyoGène), Saúl Reyes(Universidad de Los Andes), Yael Hacohen(Queen Mary University of London), Maria Pia Amato(Don Carlo Gnocchi Foundation), Aksel Sıva(Istanbul University), Christine Lebrun‐Frénay(Université Côte d'Azur), Massimo Filippi(Vita-Salute San Raffaele University), Celia Oreja‐Guevara, Melinda Magyari(University of Copenhagen)
Cited by 57
Related Papers
Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
|Annals of Neurology|2011|9.8k
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
|The Lancet Neurology|2017|8k
Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”
|Annals of Neurology|2005|5k
Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis
|New England Journal of Medicine|2016|2k
Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis
|New England Journal of Medicine|2016|1.9k